Adele C. Viguera, MD, MPH

JCP
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
Original Research

March 13, 2024

Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric...
, , , et al
JCP
Risk of PNAS in SGA-Exposed Infants
Original Research

January 4, 2023

Roughly 30% of infants exposed to SGAs in utero exhibited poor neonatal adaptation syndrome; the percentage among antidepressant-exposed infants was similar.
, , , et al
JCP
Accumulation of Reproductive Safety Data for SGAs
Commentary

June 8, 2022

This commentary on an article by Yakuwa and colleagues calls for an acceleration of the acquisition of clinical data on the safety of second-generation antipsychotics for pregnant women and...
JCP
Correction

October 5, 2021

, , , et al
JCP
Reproductive Safety of Second-Generation Antipsychotics
Original Research

August 3, 2021

What do data from a pregnancy registry demonstrate about the risk of major malformations among infants exposed to second-generation antipsychotics during the first trimester?
, , , et al
JCP
Perspectives on the New FDA Pregnancy and Lactation Labeling Rule
Academic Highlights

July 17, 2018

Pregnancy labeling of prescription medications in the US is in the midst of a major transformation. Are you aware of the changes? Read this summary of a recent conference...
, , , et al
JCP
Article

April 22, 2015

, , , et al
JCP
Article

December 27, 2011

, , , et al
JCP
Academic Highlights

October 31, 2008

, , , et al
JCP
Article

December 14, 2007

, , , et al
JCP
Article

August 15, 2007

, , , et al
JCP
Article

June 15, 2007

, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe